Form 4: Alumis Inc. Director Alan Colowick Increases Stake Through Trust
SEC Form 4 Filing
Director Alan Colowick increased his holdings in Alumis Inc. through purchases made via a revocable living trust.
Summary
- On April 1, 2025, Alan Colowick, a director of Alumis Inc., acquired 16,104 shares of common stock at a weighted-average price of $6.974 per share.
- These shares were purchased at prices ranging from $6.79 to $7.10.
- On April 2, 2025, Colowick acquired an additional 2,300 shares at a weighted-average price of $7.4935 per share, with prices ranging from $7.33 to $7.75.
- The shares are held indirectly through The Colowick Trust, for which Colowick serves as a trustee.
- Following these transactions, Colowick beneficially owns 18,404 shares through the trust.
Sentiment
Score: 7
Explanation: Insider buying is generally viewed positively, suggesting confidence in the company's prospects. However, the scale of the purchase is relatively small.
Positives
- Director's purchase may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that those with the most knowledge of the company believe its stock is undervalued.
Stakeholder Impact
- The stock purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Alan Colowick purchased 16,104 shares of Alumis Inc. common stock. |
| 04/02/2025 | Alan Colowick purchased an additional 2,300 shares of Alumis Inc. common stock. |
| 04/03/2025 | Date of signature for the Form 4 filing. |
Keywords
Alumis Inc., Director, Alan Colowick, Stock Purchase, Beneficial Ownership, Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.